Betacellulin (BTC) proteins are ligands for the EGFR/ERBB4 ligand [32], with established literature showing that BTC overexpression by HCC cells and EGFR expression by tumor-associated endothelial cells collaboratively enhance tumor vascularity via paracrine signaling [33]. The gene discussed is EGFR; the disease is hepatocellular carcinoma.